Invasive Infections in Children With Hemoglobinopathies

Sponsor

HaEmek Medical Center, Israel (Other)

Overall Status

Completed

CT.gov ID

NCT00456443

Collaborator

(none)

200

Enrollment

Location

Duration (Months)

40.3

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Patients diagnosed as having hemoglobinopathies are exposed to serious bacterial infections, principally those patients that underwent splenectomy. Since the introduction of anti pneumococcal vaccine the incidence decreased significantly but other bacteria besides encapsulated bacteria takes place as principal cause of invasive infections. The purpose of this study is to analyse in a retrospective study the incidence of those infections in a group of patients suffering from thalassemia and sickle cell anemia treated in our clinic.

Condition or Disease	Intervention/Treatment	Phase
Thalassemia Sickle Cell Anemia	Procedure: Historical records

Study Design

Study Type:

Observational

Observational Model:

Defined Population

Time Perspective:

Other

Official Title:

Invasive Infections in Children With Hemoglobinopathies. A Clinical Descriptive Retrospective Study.

Study Start Date :

Jan 1, 2006

Actual Study Completion Date :

Jun 1, 2006

Outcome Measures

Primary Outcome Measures

Eligibility Criteria

Criteria

Ages Eligible for Study:

N/A to 40 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

All patients treated in the Pediatric Hematology Unit.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Pediatric Hematology Unit and Pediatric Dpt B - HaEmek Medical Center	Afula		Israel	18101

Sponsors and Collaborators

HaEmek Medical Center, Israel

Investigators

Study Director: Ariel Koren, MD, Pediatric Hematology Unit, Ha'Emek Medical Center
Principal Investigator: Waheeb Sakran, MD, Pediatric Dpt B - Ha'Emek Medical Center